Didanosine
- 1 December 1991
- journal article
- Published by SAGE Publications in Antiviral Chemistry and Chemotherapy
- Vol. 2 (6) , 321-328
- https://doi.org/10.1177/095632029100200601
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Biological and Biochemical Studies on Ro31-6840 (2′βFddC), a Dideoxynucleoside Analogue Active Against Human Imhunodeficiency Virus Type 1 (HIV-1)Nucleosides and Nucleotides, 1991
- Immunologic issues in anti-retroviral therapyImmunology Today, 1990
- Macrophages and the human immunodeficiency virusImmunology Today, 1990
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Biochemical genetic analysis of 2′,3′-dideoxyadenosine metabolism in human T lymphocytesBiochemical and Biophysical Research Communications, 1988
- Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysisJournal of Medicinal Chemistry, 1987
- The 2′,3′-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication invitroBiochemical and Biophysical Research Communications, 1987